Last updated: January 13, 2025
Sponsor: University of Utah
Overall Status: Active - Recruiting
Phase
3
Condition
Malignant Melanoma
Melanoma
Skin Cancer
Treatment
SHINE Intervention
Clinical Study ID
NCT04341064
IRB_00118620
1R01CA244674-01
Ages 11-21 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Students are eligible for this trial if they:
- Attend high school in Utah (e.g. are enrolled in grades 9-12).
Exclusion
Exclusion Criteria:
Students will be excluded from participation if they:
Do not speak English.
Are unable to participant due to a developmental delay.
Study Design
Total Participants: 10250
Treatment Group(s): 1
Primary Treatment: SHINE Intervention
Phase: 3
Study Start date:
September 14, 2020
Estimated Completion Date:
July 28, 2025
Study Description
Connect with a study center
Huntsman Cancer Institute
Salt Lake City, Utah 84112
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.